A phase II study of irinotecan + temozolomide in children with recurrent neuroblastoma.

Trial Profile

A phase II study of irinotecan + temozolomide in children with recurrent neuroblastoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Oct 2014

At a glance

  • Drugs Irinotecan (Primary) ; Temozolomide (Primary)
  • Indications Neuroblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 02 Dec 2013 Planned End Date changed from 1 May 2007 to 1 Mar 2009 as reported by ClinicalTrials.gov record.
    • 02 Dec 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top